Vaishali Pharma Secures $73.85M Order for Antibiotic Products

Vaishali Pharma Secures $73.85M Order for Antibiotic Products

Vaishali Pharma, a leading Mumbai-based pharmaceutical company listed on NSE as VAISHALI, has been providing top-quality pharmaceutical products to corporates, hospitals, and retail stores worldwide since 1989. With a focus on meeting the needs of its customers, the company has established itself as a trusted brand in the global market and received excellent feedback.

The company’s strong commitment to providing high-quality products is supported by a team of well-qualified professionals, in-depth industry knowledge, and state-of-the-art infrastructure. Moreover, the company offers a wide range of products, including Bulk Drugs / APIs, Formulations, Surgical Products, Veterinary supplements, Herbal & Nutraceutical products, with over 250+ formulations marketed in multiple countries.

Recently, Vaishali Pharma Limited announced that it has received an order worth 73.85 Million USD from an overseas buyer for the purchase of Antibiotics Pharmaceutical products. The order was the result of six months of correspondence with the buyer, and the company is thrilled to share this news with its clients and partners. The order is subject to an initial advance payment as per the agreed terms of the contract and will be executed within 6 to 8 months. The company has done the due diligence and signed contracts with the overseas buyer, laying the foundation for a long-term business relationship.

As the company’s spokesperson stated, “Quality is an ongoing process of building and sustaining a relationship.” Therefore, Vaishali Pharma Limited always prioritizes quality in all its products, ensuring its global associations are entirely backed by quality norms. The company’s commitment to quality has helped it achieve new heights and become one of the fastest-growing and most versatile companies in the industry. Currently, the company is a supplier to all leading Indian and multinational pharmaceutical companies, catering to semi-regulated and non-regulated markets worldwide.

In conclusion, Vaishali Pharma Limited’s continuous agility, innovation, and focus on quality have made it a trusted and leading player in the supply of pharmaceutical products globally. Its robust pipeline of around 250 dossiers and synergistic collaboration with WHO-GMP manufacturing facilities have further strengthened its position. The company’s ability to adapt to new opportunities and its unwavering commitment to quality are the driving forces behind its success.

About Vaishali Pharma:

Incorporated in 1989, Vaishali Pharma Ltd. is engaged in the manufacturing, trading & marketing of Active Pharmaceutical Ingredients(APIs), pharmaceuticals formulations, surgical products, veterinary supplements, herbal, nutraceutical, and oncology products.

For More Latest News Click Here

Leave a Reply

Your email address will not be published. Required fields are marked *